HFA Icon

Nevermind Valeant – Cannacord Floats the Idea Of A Zoetis-IDEXX Deal

HFA Padded
HFA Staff
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

Forget Valeant buying Zoetis. According to some, a Zoetis-IDEXX deal would be a better fit.

Cannacord Genuity suggested in a research report on Monday that Zoetis could make a bid for IDEXX Laboratories, a Maine-based diagnostics and information solutions provider for animal health and water and milk quality. Analysts from the Canada-based investment banking and financial services firm recently met with IDEXX management in Toronto.

“Management declined to comment on noise around Zoetis’ stated interest in scaling up its animal health diagnostics business,” analysts said. “IDXX did acknowledge Zoetis’ well-respected presence in animal health; IDXX’s head of sales formerly worked at Zoetis, and at a $24B market cap with ~$600M of cash on the balance sheet and operating in a...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
HFA Padded

The post above is drafted by the collaboration of the Hedge Fund Alpha Team.